CLASS II ONGOING Device recall · Reported 11 Nov 2026 · FDA Enforcement Report

Liaison Plex Gram-Negative Blood Culture Assay recalled by Luminex

Luminex is recalling Liaison Plex Gram-Negative Blood Culture Assay, distributed nationwide in the US. The recall was initiated on 5 Oct 2026 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesAll lots UDI-DI pending
Quantity recalled30,168 test cartridges (2,514 Kits)

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-0359-2027
FDA event ID
100036
Recalling firm
Luminex, Northbrook, IL
Classification
Class II
Status
Ongoing
Recall initiated
5 Oct 2026
FDA classified
5 Nov 2026
Reported
11 Nov 2026
Type
Voluntary: Firm initiated
Reason category
Potency & Assay

Timeline

5 Oct 2026Recall initiated by company
5 Nov 2026Classified by FDA+31 days
11 Nov 2026Published in enforcement report+6 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Instructions for Use updated to include explicit guidance that repeat testing is recommended whenever a positive family-level only result is obtained. Issue may contribute to incorrect or delayed diagnosis of bloodstream infection.

Potency and specification recalls happen when a batch tests outside its approved limits for strength, purity or dissolution, which can mean the dose delivered is higher or lower than labelled.

Product as listed by the FDA

LIAISON PLEX Gram-Negative Blood Culture Assay Catalog No. 20-005-303

Where it was distributed

US distribution nationwide. No OUS distribution.

Nationwide

Questions about this recall

Why was it recalled?

Instructions for Use updated to include explicit guidance that repeat testing is recommended whenever a positive family-level only result is obtained. Issue may contribute to incorrect or delayed diagnosis of bloodstream infection.

Which lots are affected?

All lots UDI-DI pending

Where was it sold?

US distribution nationwide. No OUS distribution.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 17 Nov 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Luminex

All 40

Other Test Kits & Diagnostics recalls

All 2,675
ReportedClassRecallCompanyReasonWhere
DeviceCLASS IINextseq 550Dx Instrument recalled by IlluminaIlluminaOtherNationwide
DeviceCLASS IINovaSeq 6000Dx Instrument recalled by IlluminaIlluminaOtherNationwide
DeviceCLASS IIMiSeq Dx Instrument recalled by IlluminaIlluminaOtherNationwide
DeviceCLASS IITechno-Path Multichem AE Unassayed Level recalledTechno-path ManufacturingPotency & AssayNationwide
DeviceCLASS IITechno-Path Multichem AE Unassayed Level recalledTechno-path ManufacturingPotency & AssayNationwide